Coronary Stent Market Size (2024 - 2029)

The coronary stent market is projected to experience growth over the forecast period, driven by an increasing demand for percutaneous coronary intervention treatments due to the rising incidence of coronary artery diseases. The market's expansion is supported by the recovery from COVID-19 impacts, advancements in stent technology, and the introduction of new products by key industry players. Additionally, the growing global geriatric population and the prevalence of cardiovascular diseases are expected to further propel market growth. However, challenges such as stringent regulatory processes and a high number of product recalls may restrain the market's development.

Market Size of Coronary Stent Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Coronary Stent Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 7.41 Billion
Market Size (2029) USD 9.13 Billion
CAGR (2024 - 2029) 4.25 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Coronary Stent Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Coronary Stent Market Analysis

The Coronary Stent Market size is estimated at USD 7.41 billion in 2024, and is expected to reach USD 9.13 billion by 2029, at a CAGR of 4.25% during the forecast period (2024-2029).

The coronary stent market is undergoing substantial growth, driven by several converging trends in the global healthcare landscape. The rising prevalence of cardiovascular diseases, combined with an aging global population and rapid advancements in cardiac stent technology, is fueling the demand for coronary stents. These factors are cultivating a conducive environment for market expansion, with specific drivers playing essential roles in shaping the industry's path forward.

Increasing Prevalence of Coronary Artery Diseases (CADs): The growing incidence of coronary artery diseases is a central factor in the expansion of the coronary stent market. As per the Centers for Disease Control and Prevention, approximately 20.1 million adults aged 20 and older in the U.S. suffer from coronary artery disease, accounting for 7.2% of the population. Globally, the World Heart Federation estimates that cardiovascular diseases, including heart disease and stroke, cause nearly 18.6 million deaths annually. This rising burden of CADs is translating directly into a greater demand for interventional cardiology devices like coronary stents, which are vital in addressing blocked or narrowed arteries.

Rising Geriatric Population: The global shift towards an aging population is also significantly influencing the coronary stent market. According to the United Nations' World Population Ageing report, the global geriatric population (aged 65 years or older) is projected to reach 1.5 billion by 2050, constituting 16% of the world’s population. As older individuals are more prone to cardiovascular diseases, this demographic shift is expected to boost demand for coronary artery disease treatments. In the Asia-Pacific region, one-fourth of the population is expected to be 60 years or older by 2050, amplifying the demand for coronary stent market growth in this region.

Technological Advancements in Coronary Stents: The evolution of cardiac stent technology is playing a pivotal role in market growth. Recent innovations, such as bioresorbable stents and advanced drug-eluting stents (DES), are driving better patient outcomes. Medtronic’s FDA-approved Onyx Frontier DES and SINOMED's HT Supreme DES highlight the ongoing strides in stent delivery and post-procedural safety. These advances not only improve the efficacy of coronary stents but also widen their applicability, including in more complex coronary interventions.

Coronary Stent Industry Segmentation

As per the report's scope, coronary stents are small elastic tubes used to treat narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). The stent reduces the symptoms of chest pain (angina) and aids in treating a heart attack. These types of stents are also called heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty. 

The Coronary Stent Market is Segmented by product type, biomaterial, end-users, and geography. By product type, the market is segmented into drug-eluting stents, bare metal coronary stents, and bioabsorbable stents. By biomaterial, the market is segmented into metallic biomaterial, polymeric biomaterial, and natural biomaterial. By end-users, the market is segmented into hospitals and ambulatory surgical centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD) for the above segments.

By Product Type
Drug Eluting Stent
Bare Metal Coronary Stent
Bioabsorbable Stent
By Biomaterial
Metallic Biomaterial
Polymeric Biomaterial
Natural Biomaterial
By End User
Hospitals
Ambulatory Surgical Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Coronary Stent Market Size Summary

The coronary stent market is poised for growth, driven by the increasing incidence of coronary artery diseases and the rising demand for percutaneous coronary intervention treatments. The market is recovering from the disruptions caused by the COVID-19 pandemic, which had led to a significant reduction in cardiac surgeries and delayed diagnoses. As the pandemic's impact wanes, there has been a resurgence in heart surgeries, boosting the adoption of coronary stents. The introduction of advanced products and technologies, such as biodegradable stents and drug-eluting systems, is further propelling market expansion. The growing geriatric population, particularly in regions like Asia-Pacific, coupled with the prevalence of risk factors such as diabetes and hypertension, is expected to drive demand for stents in the coming years.

The market landscape is characterized by moderate fragmentation, with several key players like Abbott Laboratories, Medtronic Plc, and Boston Scientific Corporation actively engaging in product development and technological advancements. The launch of new drug-eluting stents and regulatory approvals are anticipated to enhance market growth, particularly in regions with high cardiovascular disease prevalence, such as China, India, and Japan. Despite the promising growth prospects, challenges such as stringent regulatory processes and product recalls may pose constraints. Nonetheless, the ongoing innovation and increasing availability of advanced stent technologies are expected to sustain the market's upward trajectory throughout the forecast period.

Explore More

Coronary Stent Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)

      2. 1.2.2 Rising Geriatric Population

      3. 1.2.3 Technological Advancements in Coronary Stents

    3. 1.3 Market Restraints

      1. 1.3.1 High Product Recalls

      2. 1.3.2 Stringent Approval Process for Stents

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - in USD)

    1. 2.1 By Product Type

      1. 2.1.1 Drug Eluting Stent

      2. 2.1.2 Bare Metal Coronary Stent

      3. 2.1.3 Bioabsorbable Stent

    2. 2.2 By Biomaterial

      1. 2.2.1 Metallic Biomaterial

      2. 2.2.2 Polymeric Biomaterial

      3. 2.2.3 Natural Biomaterial

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Surgical Centers

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Coronary Stent Market Size FAQs

The Coronary Stent Market size is expected to reach USD 7.41 billion in 2024 and grow at a CAGR of 4.25% to reach USD 9.13 billion by 2029.

In 2024, the Coronary Stent Market size is expected to reach USD 7.41 billion.

Coronary Stents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)